Tempest’s TPST-4003 is a next-generation in vivo CAR-T candidate combining proprietary CD7-targeted mRNA/LNP delivery with a ...
Tempest's TPST-4003 is a next-generation in vivo CAR-T candidate combining proprietary CD7-targeted mRNA/LNP delivery with a dual-target CD19/BCMA CAR construct designed to enable broad B-cell lineage ...
Mark Graham shares that the company plans to explore nipocalimab's potential in targeting disease-driving pathways in SLE.
Caitlin Fowler took on a lofty charity challenge to go the distance for partner Lucy Stewart who has a rare lifechanging auto ...
Belgian biopharma UCB has been given the green light by the FDA for Zilbrysq as a treatment for generalised myasthenia gravis (gMG), one of two drugs that the company hopes will shake up the market ...
James Chen, CMT is an expert trader, investment adviser, and global market strategist. Somer G. Anderson is CPA, doctor of accounting, and an accounting and finance professor who has been working in ...
Rolling Meadows, IL-based Gravis — formed in early 2024 via the combination of six dry bulk packaging solutions distributors — announced April 21 that it has acquired Western Packaging Solutions in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results